Morgan Stanley’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $458M | Buy |
|
|||||
2025
Q1 | $359M | Sell |
|
|||||
2024
Q4 | $460M | Buy |
|
|||||
2024
Q3 | $460M | Buy |
|
|||||
2024
Q2 | $374M | Buy |
|
|||||
2024
Q1 | $371M | Sell |
|
|||||
2023
Q4 | $699M | Buy |
|
|||||
2023
Q3 | $359M | Sell |
|
|||||
2023
Q2 | $375M | Buy |
|
|||||
2023
Q1 | $378M | Sell |
|
|||||
2022
Q4 | $408M | Sell |
|
|||||
2022
Q3 | $434M | Buy |
|
|||||
2022
Q2 | $364M | Buy |
|
|||||
2022
Q1 | $401M | Sell |
|
|||||
2021
Q4 | $580M | Buy |
|
|||||
2021
Q3 | $539M | Sell |
|
|||||
2021
Q2 | $552M | Sell |
|
|||||
2021
Q1 | $913M | Sell |
|
|||||
2020
Q4 | $1.24B | Buy |
|
|||||
2020
Q3 | $958M | Buy |
|
|||||
2020
Q2 | $717M | Sell |
|
|||||
2020
Q1 | $603M | Buy |
|
|||||
2019
Q4 | $635M | Buy |
|
|||||
2019
Q3 | $353M | Sell |
|
|||||
2019
Q2 | $391M | Sell |
|
|||||
2019
Q1 | $469M | Sell |
|
|||||
2018
Q4 | $406M | Buy |
|
|||||
2018
Q3 | $491M | Buy |
|
|||||
2018
Q2 | $426M | Sell |
|
|||||
2018
Q1 | $420M | Buy |
|
|||||
2017
Q4 | $396M | Sell |
|
|||||
2017
Q3 | $588M | Sell |
|
|||||
2017
Q2 | $644M | Buy |
|
|||||
2017
Q1 | $520M | Buy |
|
|||||
2016
Q4 | $405M | Buy |
|
|||||
2016
Q3 | $392M | Buy |
|
|||||
2016
Q2 | $224M | Sell |
|
|||||
2016
Q1 | $371M | Sell |
|
|||||
2015
Q4 | $622M | Sell |
|
|||||
2015
Q3 | $791M | Buy |
|
|||||
2015
Q2 | $683M | Sell |
|
|||||
2015
Q1 | $698M | Buy |
|
|||||
2014
Q4 | $540M | Sell |
|
|||||
2014
Q3 | $641M | Buy |
|
|||||
2014
Q2 | $573M | Buy |
|
|||||
2014
Q1 | $461M | Buy |
|
|||||
2013
Q4 | $241M | Sell |
|
|||||
2013
Q3 | $224M | Sell |
|
|||||
2013
Q2 | $268M | Buy |
|